NEWARK, Del, Aug. 20, 2024 (GLOBE NEWSWIRE) -- The global non surgical fat reduction market is estimated to be worth USD 1700.5 million in 2024 and is projected to be valued at USD 2932.3 million in 2034. Between 2024 and 2034, the industry is expected to register a CAGR of 5.6%.
Due to its less intrusive nature, consumers are increasingly looking for non-surgical options for fat reduction. Non-surgical techniques are more palatable to a wider range of people since they frequently entail less danger, downtime, and adverse effects.
Solutions for fat reduction are in high demand due to the global obesity pandemic. The need for efficient treatments to reduce excess fat deposits is expanding as obesity rates continue to climb globally. Non surgical solutions offer accessible and reasonably priced alternatives to surgical interventions for those who are obese.
The need for body sculpting and anti-aging products is rising as the world's population ages. This group is served by non-surgical fat reduction techniques, which offer practical solutions for age-related changes in body shape and composition.
Many people are looking for non-invasive alternatives to invasive surgeries to get their desired body aesthetics since society places a great deal of importance on physical appearance and wellness. Non-invasive fat reduction techniques provide a non-invasive way for those who want to look better and feel more confident without having to make significant lifestyle changes.
What are the Factors Restraining the Demand for Non-Surgical Fat Reduction?
The development of the non-surgical fat reduction market for obesity management has significant barriers due to the high cost of the research and development of obesity drugs and the limited financial support available. The restrictions and risks brought by the expensive development of obesity drugs may hamper the expansion of the global non-surgical fat reduction market.
Furthermore, the extended duration of research and development of drug safety as well as the introduction of clinical trials to test the drugs increases the overall expenditure within the market. Hence, manufacturers must take caution and make sure their investments in markets offer higher returns.
The high cost of surgical procedures including adjustable gastric bands, gastric bypass surgery, intragastric balloon treatment and gastric sleeve surgery, are some of the alternatives to non-surgical fat reduction, and these factors will further hinder the popularity of non-invasive fat reduction.
The factors restricting the market's growth are the lack of reimbursements and the high cost of treatment and body contouring procedures.
Full Report Now: https://www.futuremarketinsights.com/reports/non-surgical-fat-reduction-market
Key Takeaways from the Market Study:
- From 2019 to 2023, the non surgical fat reduction market expanded at a CAGR of 10.30%.
- Based on the technique, the cryolipolysis segment is expected to account for a market share of 33.50%
- The demand for non surgical fat reduction in the Germany is predicted to grow at a CAGR of 3.10% through 2034.
- In the United States, the non surgical fat reduction industry is estimated to register a CAGR of 1.7% from 2024 to 2034.
- China is projected to expand by a CAGR of 1.8% between 2024 and 2034.
- The non surgical fat reduction market in Japan is anticipated to record a CAGR of 0.90% during 2034.
“The Increasing demand for minimally invasive body contouring procedures and rising obesity rates drive the nonsurgical fat reduction market,” opines Sabyasachi Ghosh Associate Vice President at Future Market Insights (FMI).
What are the Key Opportunities for the Non-Surgical Fat Reduction Market Manufacturers?
Tedious & long working hours, behavioral risk factors like consumption of alcohol and tobacco and stress, increase the chance of leading a sedentary lifestyle, are all factors that have resulted in the progression of diseases such as diabetes and obesity.
Diabetes and obesity result in an increase in the percentage of fat in the body, which is further harmful to human health. Patients are looking for alternative methods of losing stubborn fat as a result of the increased urbanization and lack of time to focus on their physical health.
To reduce unnecessary body fat, using techniques like the non-surgical fat reduction method will boost the demand within the market. For instance, according to the International Society of Aesthetic Plastic Surgery, in 2020, over 120,707 non-surgical fat reduction surgeries were performed on males worldwide.
A growing number of appointments and consultations for various body fat treatments to enhance aesthetic appearance at many dermatological clinics is anticipated to accelerate market expansion.
Nowadays, people focus more on non-surgical treatments as they are less painful and promote faster recovery with outstanding results, thus increasing patient preference. Hence, non-surgical techniques for aesthetic purposes will boost the market demand.
Furthermore, drivers of the market expansion include variables like demand for body contouring treatments and rising acceptance of non-invasive aesthetic procedures, an increase in the prevalence of obesity, and a rise in health care spending.
Competitive Landscape:
The market players in the nonsurgical fat reduction market are investing in research and development to create innovative nonsurgical fat reduction techniques that offer improved results, shorter treatment time, and enhanced patient comfort. The market layers are collaborating with healthcare providers, aesthetic clinics, and distribution partners to expand their market reach.
- In January 2021 - Allergan Aesthetics announced the release of CoolSculpting® Elite, a next-generation fat-loss technology whose applicators enhance the body's natural contours. Targeting, freezing, and eradicating treated fat cells is possible with CoolSculpting® Elite because of its proven CoolSculpting® technology.
- The FDA has approved CoolSculpting® Elite to treat noticeable fat bulges in nine different body sites, including the flank, thigh, and abdomen; bra fat, back fat, upper arm, beneath the buttocks (sometimes called the banana roll); and the submental and submandibular regions.
Check Out the Most Recent Get Old Source Reports
Key Companies Profiled:
- Valeant Pharmaceuticals International Inc.
- Allergan plc
- Alma Lasers
- Cynosure, Inc.
- Sciton, Inc.
- Solta Medical Inc.
- Lumenis Ltd.
- Syneron Medical Ltd.
- Lutronic Corporation
- Lynton Lasers Ltd.
- Cutera Inc.
Key Market Segments Covered in the Non-Surgical Fat Reduction Industry Research:
By Technique:
- Cryolipolysis
- Ultrasound
- Low-Level Lasers
- Others
By End User:
- Hospitals
- Plastic Surgery Centers
- Cosmetic and Aesthetic Clinics
By Region:
- North America
- Latin America
- Western Europe
- Eastern Europe
- South Asia and Pacific
- East Asia
- The Middle East and Africa
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
Explore FMI’s related ongoing Coverage in the Healthcare Market Insights Domain:
The weight loss and obesity management market size is projected to rise at a CAGR of 12.8% during the projected period. The market value is projected to increase from USD 14,511 million in 2024 to USD 48,396 million by 2034.
The obesity management market share is expected to expand with a CAGR of 5.2% during the forecast period from 2023 to 2033. The overall market value is projected to grow from USD 2,095.6 million in 2023 to USD 3,494.5 million by 2033.
The body fat reduction market demand is expected to expand its roots at a steady CAGR of 9.6% during the forecast period. The market is likely to hold a revenue of USD 10.65 billion in 2023 while it is anticipated to cross a value of USD 25.6 billion by 2033.
The global HIV diagnostics market growth is estimated to be worth USD 3,497.2 million in 2024 and is anticipated to reach a value of USD 7,207.7 million by 2034. Sales are projected to rise at a CAGR of 7.5% over the forecast period between 2024 and 2034.
The contact-lens induced infections market outlook is estimated to reach USD 491.3 million in 2024. It is estimated that revenue will increase at a CAGR of 4.9% between 2024 and 2034. The market is anticipated to reach USD 792.6 million by 2034.
The self-administered biologics market overview is estimated to reach USD 94,057.6 million in 2024. It is estimated that revenue will increase at a CAGR of 4.5% between 2024 and 2034. The market is anticipated to reach USD 146,068.5 million by 2034.
The global patient transportation market sales is estimated to be worth USD 22,035.5 million in 2024 and anticipated to reach a value of USD 37,639.9 million by 2034. Sales are projected to rise at a CAGR of 5.5% over the forecast period between 2024 and 2034.
The global vascular patches market forecast is estimated to be worth USD 160.3 million in 2024 and anticipated to reach a value of USD 256.2 million by 2034. Sales are projected to rise at a CAGR of 4.8% over the forecast period between 2024 and 2034.
The MENA syringes & cannula market opportunity are estimated to be worth USD 1,592.2 million in 2024 and are anticipated to reach a value of USD 2,824.7 million by 2034. Sales are projected to rise at a CAGR of 5.9% over the forecast period between 2024 and 2034.
The carbon dioxide incubators market strategies is estimated to reach USD 752.9 million in 2024. It is estimated that revenue will increase at a CAGR of 5.1% between 2024 and 2034. The market is anticipated to reach USD 1,238.1 million by 2034.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Join us as we commemorate 10 years of delivering trusted market insights. Reflecting on a decade of achievements, we continue to lead with integrity, innovation, and expertise.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
